Your trusted destination for CME, CPD & Medical Education across the Middle East.
This hybrid international conference focuses on the latest research, advancements, and collaborative strategies in pediatric infectious diseases, vaccines, and immunology, bringing together global experts and researchers.
The International Conference on Pediatric Infectious Diseases, Vaccines and Immunology (ICPIDVI-26) is a two-day hybrid international conference taking place on 9–10 October 2026 in Riyadh, Saudi Arabia. Organized by Research Plus, the conference provides a platform for researchers, scientists, academics, healthcare professionals, and industry representatives to exchange knowledge and discuss current developments in pediatric infectious diseases, vaccinology, and immunology. The scientific programme explores important developments in the prevention, diagnosis, and management of infectious diseases affecting children. Discussions cover recent research into the etiology, pathogenesis, epidemiology, diagnosis, and treatment of pediatric infections, as well as emerging trends in the global burden and spread of childhood infectious diseases. A major focus of the conference is pediatric vaccination and vaccinology. Sessions examine innovative vaccination strategies, new vaccine candidates and delivery approaches, pediatric vaccine clinical trials, vaccine efficacy and safety, immunization schedules, and challenges associated with vaccine hesitancy. The programme also considers public health strategies aimed at improving vaccine confidence and immunization coverage among children and communities. The conference further addresses pediatric immunology, including the ways children's immune systems respond to infectious agents and vaccines. Topics include vaccine-induced immunity and the clinical implications of primary and secondary immunodeficiencies, providing participants with broader perspectives on the relationship between immune function and susceptibility to pediatric infections. In addition to scientific presentations, ICPIDVI-26 provides opportunities for researchers and healthcare professionals to present original work through oral and poster presentations. Keynote sessions, technical discussions, and opportunities for professional networking allow participants to exchange research findings, clinical experiences, and perspectives with an international community of professionals. The hybrid format enables participants to attend either in person or virtually, supporting broader participation and international knowledge exchange. The conference also provides opportunities for research collaboration and recognition of outstanding contributions through Best Paper and Best Presentation awards. ICPIDVI-26 is relevant to pediatricians, infectious disease physicians, immunologists, researchers, scientists, clinicians, family physicians, general practitioners, nurses, pharmacists, public health professionals, epidemiologists, and medical students. Through its multidisciplinary scientific programme, the conference aims to promote knowledge exchange, collaboration, and continued discussion of advances in pediatric infectious diseases, vaccines, and immunology.
Exploring the latest findings in the etiology, pathogenesis, and treatment of infectious diseases affecting children.
Analyzing the spread, prevalence, and impact of key pediatric infectious diseases on a global scale.
Discussing best practices and novel techniques for the diagnosis and clinical care of pediatric infections.
Covering the development of new vaccines, advanced delivery systems, and optimized immunization schedules for children.
Reviewing the outcomes, efficacy, and safety profiles from recent and ongoing pediatric vaccine clinical trials.
Addressing the challenges of vaccine hesitancy and strategies to improve vaccine uptake and public trust.
Understanding the unique aspects of the pediatric immune system and its response to pathogens and antigens.
Investigating the mechanisms of immune protection generated by various pediatric vaccines.
Exploring congenital and acquired immune disorders in children and their implications for infectious disease susceptibility.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
| Registration | Category | Valid Until | Price |
|---|---|---|---|
| Author Presentation | Early Bird Registration | Sep 09, 2026 | USD 499 |
| Author Presentation | Standard Registration | Sep 24, 2026 | USD 539 |
| Author Presentation with Scopus Publication | Early Bird Registration | Sep 09, 2026 | USD 709 |
| Author Presentation with Scopus Publication | Standard Registration | Sep 24, 2026 | USD 749 |
| Author Presentation with Q2 Scopus Publication | Early Bird Registration | Sep 09, 2026 | USD 1,909 |
| Author Presentation with Q2 Scopus Publication | Standard Registration | Sep 24, 2026 | USD 2,129 |
| Author Presentation with Q3 Scopus Publication | Early Bird Registration | Sep 09, 2026 | USD 1,569 |
| Author Presentation with Q3 Scopus Publication | Standard Registration | Sep 24, 2026 | USD 1,799 |
| Listener / Attendee | Early Bird Registration | Sep 09, 2026 | USD 249 |
| Listener / Attendee | Standard Registration | Sep 24, 2026 | USD 299 |
| Virtual Keynote Speaker Registration | Early Bird Registration | Sep 09, 2026 | USD 349 |
| Virtual Keynote Speaker Registration | Standard Registration | Sep 24, 2026 | USD 359 |
| Pre-recorded Video Submission | Early Bird Registration | Sep 09, 2024 | USD 279 |
| Pre-recorded Video Submission | Standard Registration | Sep 24, 2026 | USD 299 |
| Virtual Presentation | Early Bird Registration | Sep 09, 2026 | USD 269 |
| Virtual Presentation | Standard Registration | Sep 24, 2026 | USD 309 |
| Virtual Presentation with Scopus Publication | Early Bird Registration | Sep 09, 2026 | USD 619 |
| Virtual Presentation with Scopus Publication | Standard Registration | Sep 24, 2026 | USD 649 |
| Virtual Presentation with Q2 Scopus Publication | Early Bird Registration | Sep 09, 2026 | USD 1,629 |
| Virtual Presentation with Q2 Scopus Publication | Standard Registration | Sep 24, 2026 | USD 1,849 |
| Virtual Presentation with Q3 Scopus Publication | Early Bird Registration | Sep 09, 2026 | USD 1,349 |
| Virtual Presentation with Q3 Scopus Publication | Standard Registration | Sep 24, 2026 | USD 1,629 |
| Virtual Attendance (Listener) | Early Bird Registration | Sep 09, 2026 | USD 179 |
| Virtual Attendance (Listener) | Standard Registration | Sep 24, 2026 | USD 209 |